Respiratory Syncytial Virus (RSV) Vaccine: Breakthrough Therapy RSVpreF Approved by FDA
Recently, the US Food and Drug Administration (FDA) has granted respiratory syncytial virus (RSV) bivalent pre-fused F subunit vaccine (RSVpreF) breakthrough therapy recognition (BTD), which is an active immunization for the pregnantRead More…